Maze Therapeutics - Matrix Capital Management Master Fund LP Beneficially Owned 7.1% of Common Shares Prior to Offering
Maze Therapeutics - Matrix Capital Management Master Fund LP 在增发前拥有7.1%的普通股权益
Maze Therapeutics - Matrix Capital Management Master Fund LP Beneficially Owned 7.1% of Common Shares Prior to Offering
Maze Therapeutics - Matrix Capital Management Master Fund LP 在增发前拥有7.1%的普通股权益
使用浏览器的分享功能,分享给你的好友吧